H. Safayhi et al., INHIBITION BY BOSWELLIC ACIDS OF HUMAN-LEUKOCYTE ELASTASE, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 460-463
Frankincense extracts and boswellic acids, biologically active pentacy
clic triterpenes of frankincense, block leukotriene biosynthesis and e
xert potent anti-inflammatory effects. Screening for additional effect
s of boswellic acids on further proinflammatory pathways, we observed
that acetyl-11-keto-beta-boswellic acid, an established direct, nonred
ox and noncompetitive 5-lipoxygenase inhibitor, decreased the activity
of human leukocyte elastase (HLE) in vitro with an IC50 value of abou
t 15 mu M. Among the pentacyclic triterpenes tested in concentrations
up to 20 mu M, we also observed substantial inhibition by beta-boswell
ic acid, amyrin and ursolic acid, but not by 18 beta-glycyrrhetinic ac
id. The data show that the dual inhibition of 5-lipoxy-genase and HLE
is unique to boswellic acids: other pentacyclic triterpenes with HLE i
nhibitory activities (e.g., ursolic acid and amyrin) do not inhibit 5-
lipoxygenase, and leukotriene biosynthesis inhibitors from different c
hemical classes (e.g., NDGA, MK-886 and ZM-230,487) do not impair HLE
activity. Because leukotriene formation and HLE release are increased
simultaneously by neutrophil stimulation in a variety of inflammation-
and hypersensitivity-based human diseases, the reported blockade of tw
o proinflammatory enzymes by boswellic acids might be the rationale fo
r the putative antiphlogistic activity of acetyl-11-keto-beta-boswelli
c acid and derivatives.